Skip to main content

Sitagliptin Performs Well in Early Studies : Novel compound significantly reduces glucose and is well tolerated in patients with type 2 diabetes.

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Sitagliptin Performs Well in Early Studies : Novel compound significantly reduces glucose and is well tolerated in patients with type 2 diabetes.

User login

Username

Password

Reset your password

Type	Lead	score